Susquehanna analyst Christopher Rolland maintains ON Semiconductor (NASDAQ:ON) with a Positive and raises the price target from $65 to $75.
BTIG Downgrades Talis Biomedical to Sell, Announces $1 Price Target
BTIG analyst Mark Massaro downgrades Talis Biomedical (NASDAQ:TLIS) from Neutral to Sell and announces $1 price target.